United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Pharma Industry News Ernexa’s ERNA-101 cell therapy takes major step toward clinical trials through Cellipont manufacturing deal Discover how Ernexa Therapeutics and Cellipont Bioservices are teaming up to manufacture ERNA-101 for ovarian cancer, marking a milestone in allogeneic cell therapy. bySoujanya RaviOctober 29, 2025